This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Keyence Fluorescence Microscope
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health intends to award a non-competitive contract to Keyence Corporation of America for a Keyence BZ-X1000 fluorescence microscope system, including stitch multi-point imaging, Z-stacking modules, and the BZX analyzer software, along with 2X, 10X, 20X, and 40X fluorite phase or apochromat objectives. This acquisition is part of the Undiagnosed Diseases Program’s effort to conduct high-sensitivity cellular analyses to determine the genetic and mechanistic basis of rare, undiagnosed conditions in patients. The procurement will be conducted under the Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, not exceeding the $350,000 threshold, and is authorized for sole-source negotiation due to the specific technical and operational requirements that only this system can fulfill. The contract will incorporate all applicable provisions from FAC 2026-01 and will not be subject to full competitive requirements under FAR Part 6. The solicitation number is 75N98026Q00438, posted on May 22, 2026, with a response deadline of June 1, 2026. The contract is classified under NAICS code 423830, and no set-aside designation applies. All responses must include a technical and cost proposal, period of performance, Unique Entity ID, Taxpayer Identification Number, business size certification, and an active SAM registration, and must be submitted electronically to the designated contracting officer by the deadline. While the government has expressed its intent to proceed without competition, it is inviting all responsible sources to submit capability statements for review, though the final decision on whether to pursue a competitive or non-competitive award rests solely with the agency. The primary point of contact for submissions is James Law at the NIH Office of Acquisition and Logistics Management in Bethesda, Maryland, with performance expected to occur in Itasca, Illinois.
General Info
Agency
NAICS
Place of Performance
Itasca, IL, 60143, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00438
Posted Date:
May 22, 2026
Original Response Date:
June 1, 2026
Current Response Date:
June 1, 2026
Set Aside:
N/A
NAICS Code:
423830
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Keyence Corporation of America
500 Park Boulevard Suite 200 Itasca IL 60143
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 423830 .
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Keyence Fluorescence Microscope
- Background Information: The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency conducting and supporting medical discoveries that improve people’s health and save lives. The National Institutes of Health Undiagnosed Diseases Program (UDP) is a program designed to address the needs of persons with debilitating medical conditions for which no diagnosis has been found despite an extensive workup. The goals of the UDP include finding accurate diagnoses and discovering new diseases that provide insight into human physiology and genetics. The UDP was established to evaluate participants who have undiagnosed medical conditions. UDP participants have generally received extensive diagnostic workups before traveling to the NIH and often have numerous and/or complex medical problems. The UDP program makes use of a diverse set of diagnostic and research techniques both to attempt to find a diagnosis and to generate research projects to advance medical knowledge. Cells from admitted Undiagnosed Disease patients will be used to perform necessary biological laboratory experiments to determine the mechanism of the patients’ disease. he Keyence BZ-X1000 fluorescence microscope package including the stitch multi-point image and Z-stacking modules, along with 2X, 10X, 20X, and 40X fluorite phase or apochromat objectives and the BZX analyzer software will allow the laboratory to perform necessary high-sensitivity cellular experiments and analysis to determine the cellular mechanisms involved in patient genetic mutations..
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by June 1, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00438. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
